Clinical Trial Update: 18F-FluorThanatrace (PET/CT) in Glioblastoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluating 18F-FluorThanatrace PET/CT in glioblastoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• 18F-FluorThanatrace

Snippet

Sponsor: University of Pennsylvania | Conditions: Glioblastoma | EARLY_Phase 1 | Status: TERMINATED